MyFinsight
Home
Blog
About
Product
$157,513K
(-3.03%↓ Y/Y)
License And Other
Revenues
$60,737K
Total revenues
$218,250K
(33.61%↑ Y/Y)
Income (loss) from
operations
$98,465K
(230.57%↑ Y/Y)
Total operating
expenses
$119,785K
(-10.32%↓ Y/Y)
Income (loss) before
income taxes
$79,474K
(1125.32%↑ Y/Y)
Total other expense,
net
-$18,991K
(18.49%↑ Y/Y)
Interest income
$2,434K
(-3.26%↓ Y/Y)
Other income
(expense), net
$260K
Foreign currency gains
(losses), net
$27K
(142.86%↑ Y/Y)
Selling, general and
administrative
$63,976K
(-26.79%↓ Y/Y)
Research and development
$51,969K
(19.78%↑ Y/Y)
Cost of product sales
$3,840K
(37.24%↑ Y/Y)
Net income (loss)
$78,395K
(1441.69%↑ Y/Y)
Income tax expense
$1,079K
(-22.98%↓ Y/Y)
Interest expense
$21,712K
(0.60%↑ Y/Y)
Net comprehensive
income (loss)
$78,235K
(1297.30%↑ Y/Y)
Total other
comprehensive (loss) income
-$160K
(-131.13%↓ Y/Y)
Unrealized gain on
available for sale...
-$133K
(29.26%↑ Y/Y)
Foreign currency
translation adjustment
-$27K
(-103.85%↓ Y/Y)
Back
Back
Income Statement
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)
source: myfinsight.com